{
    "id": 32705,
    "fullName": "WNK1 - ROS1",
    "impact": "fusion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "WNK1-ROS1 results from the fusion of WNK1 and ROS1 (PMID: 30797499). WNK1-ROS1 has been identified in non-small cell lung cancer (PMID: 30797499), but has not been biochemically characterized and therefore, the effect on protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 17997,
                    "pubMedId": 30797499,
                    "title": "Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30797499"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 65125,
        "geneSymbol": "WNK1",
        "terms": [
            "WNK1",
            "HSAN2",
            "HSN2",
            "KDP",
            "p65",
            "PPP1R167",
            "PRKWNK1",
            "PSK"
        ]
    },
    "variant": "WNK1 - ROS1",
    "createDate": "03/04/2020",
    "updateDate": "03/09/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 6098,
                "geneSymbol": "ROS1",
                "terms": [
                    "ROS1",
                    "c-ros-1",
                    "MCF3",
                    "ROS"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 20762,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with WNK1-ROS1 positive non-small cell lung cancer treated with Xalkori (crizotinib) demonstrated a partial response after three months, but developed resistance with the emergence of a secondary mutation, ROS1 G2032R, leading to disease progression after five months (PMID: 30797499).",
            "molecularProfile": {
                "id": 35328,
                "profileName": "WNK1 - ROS1"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17997,
                    "pubMedId": 30797499,
                    "title": "Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30797499"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20763,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with WNK1-ROS1 positive non-small cell lung cancer initially responded to treatment with Xalkori (crizotinib), but developed resistance with the emergence of a secondary mutation, ROS1 G2032R, leading to disease progression after five months (PMID: 30797499).",
            "molecularProfile": {
                "id": 35329,
                "profileName": "WNK1 - ROS1 ROS1 G2032R"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17997,
                    "pubMedId": 30797499,
                    "title": "Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30797499"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35328,
            "profileName": "WNK1 - ROS1",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35329,
            "profileName": "WNK1 - ROS1 ROS1 G2032R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}